Os Therapies Inc. is a biotechnology company focused on the development and commercialization of innovative cancer treatments. Their primary function is to research and produce therapies aimed at improving the prognosis and quality of life for cancer patients. The company is particularly engaged in the immunotherapy sector, conducting trials and developing products that help harness the body’s immune system to fight cancer. Os Therapies Inc. plays a significant role in the biotechnology and pharmaceutical industries by striving to bring transformative solutions to oncological challenges. As part of the broader healthcare sector, their work contributes to advancements in personalized medicine and addresses pressing needs in cancer treatment methodologies. Through its cutting-edge research and dedicated approach, Os Therapies Inc. seeks to make impactful contributions to both patients' lives and the scientific community's understanding of cancer treatment.